Home › Post-COVID Conditions (Long COVID) › NCT06006884
A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
RecruitingObservational study
Uncover Mechanisms Underlying the Development of Chronic Lung Sequelae Post COVID-19
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: For the Sequelae Group * Age ≥18 years at screening, PCR confirmed COVID19 illness (+PCR defines day 0 of illness), hospitalization for COVID-19, absence of pre-existing history of interstitial lung disease, or significant other lung disease. * Severity of illness will be categorized as moderate disease (supplemental oxygen need 1-8L at any time during hospitalization), severe disease (need for high flow oxygen delivery ≥8L at any time during hospitalization) and critical illness (need for ICU admission or mechanical ventilation). Control Recovery Group * Age ≥18 years at screening * PCR confirmed COVID-19 cases who had nonsymptomatic or mild acute infection that do not require hospitalization 7,48,49 * Absence of pre-existing history of interstitial lung disease, or significant other lung disease, absence of any ongoing respiratory and systemic symptoms. Exclusion Criteria: * Inability to provide informed consent, evidence of pre-existing interstitial lung disease or chronic lung disease; * Active cigarette smoking, vaping or other inhalation use. * Immunocompromised host status due to ongoing therapy with methotrexate, CellCept, azathioprine, rituximab, cyclophosphamide or other biologic agents; * \> 20 pack year smoking history. * History of chemotherapy or radiation therapy in the last two years; and pregnancy.
About the study
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infection
What is being tested
- Bronchoscopies and Bronchoalveolar Lavages (BALs) (procedure)
- Chest Tomography (CT) (diagnostic test)
- Electrocardiogram (ECG) (diagnostic test)
- Pulmonary function tests (PFTs) (diagnostic test)
- 6 minute walk test (6MWT) (diagnostic test)
Sponsor: Mayo Clinic · Participants: 67 · Started: Jan 10, 2024
Contact the study team
Official record on ClinicalTrials.gov — NCT06006884
Locations in the U.S.
| Minnesota | Mayo Clinic Minnesota, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.